ZAG | S&W

News

The Firm continues to lead in the International rankings The Legal 500 EMEA in areas: Hi-Tech, Capital Markets,Trade and M&A

24.04.2017
Dun's 100 - 2017 edition has ranked ZAG-S&W among the leading law firms in Israel

24.04.2017
ZAG- S&W continues to be ranked and reccommended by IFLR 2017 as one of the leading law firms

24.04.2017
US office Ranked in the 2017 Edition of Chambers USA

26.05.2017
UK office wins second year "Best Trade Finance Law Firm

26.05.2017
US Office Ranked in the 2017 edition of The Legal 500 United States

31.05.2017
The firm has been ranked again this year among the leading firms by the Ranking BDiCode

01.06.2017
"Winning Tactics in Tenders" - a seminar held by the firm in cooperation with the ACC-Israel, led by Tomer Raif, Head of the Litigation and Tenders dept.

04.07.2017

Transactions and IPOs

DarioHealth Corp. Prices offering of 1,450,000 Shares of Common Stock in amount of approx $4.5 million

DarioHealth Corp. Prices offering of 1,450,000 Shares of Common Stock in amount of approx $4.5 million

ZAG-S&W represented Therapix Biosciences in $13.8 Million Initial Public Offering

ZAG-S&W represented Therapix Biosciences in $13.8 Million Initial Public Offering

Pluristem Therapeutics Ltd. received a public offering at a value of $17.25 million

Pluristem Therapeutics Ltd. received a public offering at a value of $17.25 million

Capital Raising for Insuline Medical ltd. at a sum of NIS 8,192,930

Capital Raising for Insuline Medical ltd. at a sum of NIS 8,192,930

HBL- Hadasit Bio-Holdings raised NIS 4.8 in a right offering

HBL- Hadasit Bio-Holdings raised NIS 4.8 in a right offering

IVC research center and ZAG-S&W report reveals that during the first quarter of 2017 investments in young start- ups have been growing

IVC research center and ZAG-S&W report reveals that during the first quarter of 2017 investments in young start- ups have been growing